Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3... ...http://www.asianhhm.com/press/pressrelease_archives.asp?PID=11597&title=Merck-Initiates-Phase-3-Study-of-Letermovir-an-Investigational-Antiviral-for-Prevention-of-Cytomegalovirus-CMV-Infection-in-HighRisk-Bone-Marrow-Transplant-Patients
Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including next-generation sequencing... ...http://www.asianhhm.com/press/pressrelease_archives.asp?PID=11598&title=QIAGEN-Adds-Promising-Genomic-Biomarkers-for-Assessing-Prognosis-in-Treatment-of-Blood-Cancers-to-Personalized-Healthcare-Pipeline
/PRNewswire-iReach/ -- The struggle to lose weight is long and one which can cost a great deal of money. While some choose the nation's most... ...http://www.itnewsonline.com/prnewswire/Health-Briefs-Reviews-the-Weight-Loss-Strategies/335078
Barbara J. Ryan has been reappointed, without competition, to a second, three year term as the Secretariat Director of the Group on Earth... ...http://www.ibrnews.biz/2014/07/barbara-j-ryan-reappointed-geo.html
/PRNewswire/ --Building on a partnership spanning more than 20 years, Colgate-Palmolive proudly joined the National Dental Association (NDA) today... ...http://in.advfn.com/p.php?pid=nmona&article=63034389
IHF ORBITARUM is the first wellness...